Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders 75N98026R00007
Summary
AI-generated · Feb 18, 2026Develop formulations, manufacture, perform quality control testing, conduct stability studies, and distribute pharmaceutical dosage forms to be used in preclinical and clinical studies within a medications development program for treating substance use disorders. Treatments may involve new chemical entities or previously approved drug substances, with drug substances obtained from private industry, government contractors/grantees, or independent investigators.
This is a sources-sought to identify qualified organizations capable of providing these development and manufacturing services as a resource for the medications development program; see the attached Sources Sought Notice for details.
The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Pleas see SSN attached.
From Sources Sought posted on Feb 17, 2026Notice history
1-
Sources Sought LATEST Posted Feb 17, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Phone
Agency
Place of Performance
USA